AbbVie ABBV has gained 22.5% so far this year against a decrease of 0.1% for the industry. The stock has also outperformed ...

AbbVie Inc. (NYSE:ABBV) is included among the 13 Best Consistent Dividend Stocks to Buy Now. AbbVie Inc. (NYSE:ABBV) is an ...

Now, the Chicago pharma has done just that by striking a deal with a slate of generics manufacturers that waylays the entry ...

This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors.

AbbVie doesn’t expect generic Rinvoq products to be launched in the United States before April 2037, per an MSN report.

A study reveals that switching from Humira to Amgevita for IBD maintains disease control and offers significant cost savings.

Three Motley Fool contributors believe they've found healthcare stocks that you can buy and hold forever. Here's why they ...

Investing $50,000, for example, could be at least somewhat nerve-wracking for some. The key to lowering your anxiety with a ...

AbbVie Inc. (NYSE: ABBV), a biopharmaceutical company spun off from Abbott Laboratories, has delivered a total return of 494% ...

AbbVie has performed better than the market over the past decade. The company has lost a major product, but its lineup and pipeline remain strong. AbbVie still has a solid business and boasts a strong ...

AbbVie (ABBV) stock in focus as the company settles with generic drugmakers to resolve litigation related to copycat versions ...